[1]
|
Faddy, M.J., Gosden, R.G., Gougeon, A., Richardson, S.J. and Nelson, J.F. (1992) Accelerated Disappearance of Ovarian Follicles in Mid-Life: Implications for Forecasting Menopause. Human Reproduction, 7, 1342-1346.
|
[2]
|
Cahill, D.J., Prosser, C.J., Wardle, P.G., Ford, W.C.L. and Hull, M.G.R. (1994) Relative Influence of Serum Follicle Stimulating Hormone, Age, and Other Factors on Ovarian Response to Gonadotrophin Stimulation. BJOG: An International Journal of Obstetrics & Gynaecology, 101, 999-1002.
|
[3]
|
Hull, M.G.R., Fleming, C.F., Hughes, A.O. and McDermott, A. (1996) The Age-Related Decline in Female Fecundity: A Quantitative Controlled Study of Implanting Capacity and Survival of Individual Embryos after in Vitro Fertilization. Fertility and Sterility, 65, 783-790.
|
[4]
|
La Marca, A., Sighinolfi, G., Radi, D., Argento, C., Baraldi, E., Artenisio, A.C., Stabile, G. and Volpe, A. (2010) Anti-Müllerian Hormone (AMH) as a Predictive Marker in Assisted Reproductive Technology (ART). Human Reproduction Update, 16, 113-130. http://dx.doi.org/10.1093/humupd/dmp036
|
[5]
|
Anderson, R.A., Nelson, S.M. and Wallace, W.H.B. (2012) Measuring Anti-Müllerian Hormone for the Assessment of Ovarian Reserve: When and for Whom Is It Indicated? Maturitas, 71, 28-33.
http://dx.doi.org/10.1016/j.maturitas.2011.11.008
|
[6]
|
Nelson, S.M., Yates, R.W. and Fleming, R. (2007) Serum Anti-Müllerian Hormone and FSH: Prediction of Live Birth and Extremes of Response in Stimulated Cycles—Implications for Individualization of Therapy. Human Reproduction, 22, 2414-2421. http://dx.doi.org/10.1093/humrep/dem204
|
[7]
|
Nelson, S.M., Yates, R.W., Lyall, H., Jamieson, M., Traynor, I., Gaudoin, M., Mitchell, P., Ambrose, P. and Fleming, R. (2009) Anti-Müllerian Hormone-Based Approach to Controlled Ovarian Stimulation for Assisted Conception. Human Reproduction, 24, 867-875. http://dx.doi.org/10.1093/humrep/den480
|
[8]
|
Nardo, L.G., Fleming, R., Howles, C.M., Bosch, E., Hamamah, S., Ubaldi, F.M., Hugues, J.N., Balen, A.H. and Nelson, S.M. (2011) Conventional Ovarian Stimulation No Longer Exists: Welcome to the Age of Individualized Ovarian Stimulation. Reproductive BioMedicine Online, 23, 141-148. http://dx.doi.org/10.1016/j.rbmo.2011.05.008
|
[9]
|
Yates, A.P., Rustamov, O., Roberts, S.A., Lim, H.Y., Pimberton, P.W., Smith, A. and Nardo, L.G. (2011) Anti-Mullerian Hormone-Tailored Stimulation Protocols Improve Outcomes Whilst Reducing Adverse Effects and Costs of IVF. Human Reproduction, 26, 2353-2362. http://dx.doi.org/10.1093/humrep/der182
|
[10]
|
Steiner, A.Z., Herring, A.H., Kenser, J.S., et al. (2011) Antimullerian Hormone as Predictor of Natural Fecundability in Women Aged 30-42 Years. Obstetrics & Gynecology, 117, 798-804.
http://dx.doi.org/10.1097/AOG.0b013e3182116bc8
|
[11]
|
Broekmans, F.J., Kwee, J., Hendriks, D.J., Mol, B.W. and Lambalk, C.B. (2006) A Systematic Review of Tests Predicting Ovarian Reserve and IVF Outcome. Human Reproduction Update, 12, 685-718.
http://dx.doi.org/10.1093/humupd/dml034
|
[12]
|
Bhide, P., Gudi, A., Shah, A., Timms, P., Grayson, K. and Homburg, R. (2013) Anti-Müllerian Hormone as a Predictor of Pregnancy Following IVF. Reproductive BioMedicine Online, 26, 247-252.
http://dx.doi.org/10.1016/j.rbmo.2012.11.018
|
[13]
|
Weghofer, A., Dietrich, W., Barad, D.H. and Gleicher, N. (2011) Live Birth Chances in Women with Extremely Low Serum Anti-Mullerian Hormones Levels. Human Reproduction, 26, 1905-1909.
http://dx.doi.org/10.1093/humrep/der134
|
[14]
|
Kailasam, C., Hunt, L., Ryder, I., Bhakri, I. and Gordon, U.D. (2008) Safety and Effectiveness of Diclofenac Sodium in Assisted Reproduction Treatment: A Randomized Prospective Double-Blind Study. Reproductive BioMedicine Online, 16, 724-729. http://dx.doi.org/10.1016/S1472-6483(10)60488-9
|
[15]
|
Gleicher, N., Weghofer, A. and Barad, D.H. (2010) Antimullerian Hormone (AMH) Defines Independent of Age, Low versus Good Live Birth Chances in Women with Severely Diminished Ovarian Reserve. Fertility and Sterility, 94, 2824-2827. http://dx.doi.org/10.1016/j.fertnstert.2010.04.067
|
[16]
|
Barad, D.H., Weghofer, A. and Gleicher, N. (2009) How Predictive of Basic Pregnancy Potential Are Extremely Low Levels of Anti-Mullerian Hormone (AMH). Fertility and Sterility, 92, 178-179.
|
[17]
|
Kedem, A., Haas, J., Geva, L.L., Yerushalmi, G., Gilboa, Y., Kanety, H., Hanochi, M., Maman, E. and Hourvitz, A. (2013) Ongoing Pregnancy Rates in Women with Low and Extremely Low AMH Levels. A Multivariate Analysis of 769 Cycles. PLoS ONE, 8, e81629. http://dx.doi.org/10.1371/journal.pone.0081629
|
[18]
|
Lukaszuk, K., Kunicki, M., Liss, J., Bednarowska, A. and Jakiel, G. (2014) Probability of Live Birth in Women with Extremely Low Anti-Müllerian Hormone Concentrations. Reproductive BioMedicine Online, 28, 64-69.
http://dx.doi.org/10.1016/j.rbmo.2013.09.017
|
[19]
|
Society for Assisted Reproductive Technology. IVF Success Rates, National Data Summary.
http://www.sart.org/fram/detail.aspx?id=3893
|
[20]
|
Coccia, M.E. and Rizzello, F. (2008) Ovarian Reserve. Annals of New York Academy of Sciences, 1127, 27-30.
http://dx.doi.org/10.1196/annals.1434.011
|
[21]
|
Check, J.R., Nazari, P., Check, M.L., Choe, J.K. and Liss, J.R. (2002) Prognosis Following in Vitro Fertilization-Embryo Transfer (IVF-ET) in Patients with Elevated Day 2 or 3 Serum Follicle Stimulating Hormone (FSH) Is Better in Younger vs Older Patients. Clinical Experimental Obstetrics Gynecology, 29, 42-44.
|
[22]
|
Smeenk, J.M., Sweep, F.C., Zielhuis, G.A., et al. (2007) Antimullerian Hormone Predicts Ovarian Responsiveness, but Not Embryo Quality or Pregnancy, after in Vitro Fertilization or Intracytoplasmic Sperm Injection. Fertility and Sterility, 87, 223-226. http://dx.doi.org/10.1016/j.fertnstert.2006.06.019
|
[23]
|
Overbeek, A., Broekmans, F.J., Hehenkamp, W.J., Wijdeveld, M.E., van Disseldorp, J., van Dulmen-den, B.E. and Lambalk, C.B. (2012) Intra-Cycle Fluctuations of Anti-Müllerian Hormone in Normal Women with a Regular Cycle: A Reanalysis. Reproductive BioMedicine Online, 24, 664-669. http://dx.doi.org/10.1016/j.rbmo.2012.02.023
|
[24]
|
Wunder, D.M., Bersinger, N.A., Yared, M., Kretschmer, R. and Birkhauser, M.H. (2008) Statistically Significant Changes of Antimullerian Hormone and Inhibin Levels during the Physiologic Menstrual Cycle in Reproductive Age Women. Fertility and Sterility, 89, 927-933. http://dx.doi.org/10.1016/j.fertnstert.2007.04.054
|
[25]
|
Buyuk, E., Seifer, D.B., Younger, J., Grazi, R.V. and Lieman, H. (2011) Random Anti-Müllerian Hormone (AMH) Is a Predictor of Ovarian Response in Women with Elevated Baseline Early Follicle-Stimulating Hormone Levels. Fertility and Sterility, 95, 2369-2372. http://dx.doi.org/10.1016/j.fertnstert.2011.03.071
|
[26]
|
Nelson, S.M. (2012) Chapter 25: The Patient with Poor Ovarian Reserve. In: Sharif, K. and Coomarasamy, A., Eds., Assisted Reproduction Techniques: Challenges and Management Options, Wiley-Blackwell, Oxford, 99-104.
|